CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples

<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least part...

Full description

Saved in:
Bibliographic Details
Main Authors: Ron Lee (Author), Sally Ullery (Author), Ron Thomason (Author)
Format: Book
Published: Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2020-05-01.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahcrr_000022
042 |a dc 
100 1 0 |a Ron Lee  |e author 
700 1 0 |a  Sally Ullery  |e author 
700 1 0 |a Ron Thomason  |e author 
245 0 0 |a CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples 
260 |b Archives of Hematology Case Reports and Reviews - Peertechz Publications,   |c 2020-05-01. 
520 |a <p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least partial CD103 expression (31-92% positive) with the majority having significant expression of CD103. </p> 
540 |a Copyright © Ron Lee et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/ahcrr.000022  |z Connect to this object online.